The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Mutation profile of drug resistant gastrointestinal stromal tumor (GIST) patients (pts) enrolled in the phase 1 study of DCC-2618.
 
Suzanne George
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie (I)
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; deciphera
Research Funding - ARIAD (Inst); Bayer (Inst); Blueprint Medicines (Inst); Deciphera (Inst); Novartis (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - UptoDate
 
Michael C. Heinrich
Stock and Other Ownership Interests - MolecularMD
Honoraria - Novartis
Consulting or Advisory Role - ARIAD; Bayer; Blueprint Medicines; Deciphera; MolecularMD; Novartis; Pfizer
Research Funding - ARIAD (Inst); Blueprint Medicines (Inst); Deciphera (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patent on treatment of GIST-licensed to Novartis (Inst)
Expert Testimony - Novartis
 
Albiruni Ryan Abdul Razak
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; Merck
Research Funding - Amgen; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; CASI Pharmaceuticals; Deciphera; Karyopharm Therapeutics; Lilly; MedImmune; Novartis; Pfizer; Roche/Genentech
 
Ping Chi
Employment - Pfizer (I)
Honoraria - Novartis
Consulting or Advisory Role - Deciphera
 
Michael S. Gordon
Stock and Other Ownership Interests - Caremission; WCCT Global
Consulting or Advisory Role - Castle Biosciences; Deciphera; RedHill Biopharma; TRACON Pharma
Research Funding - Abbvie (Inst); Acetylon Pharmaceuticals (Inst); Aduro Biotech (Inst); Advaxis (Inst); Amgen (Inst); Amgen (Inst); Array BioPharma (Inst); BeiGene (Inst); BiolineRx (Inst); Calithera Biosciences (Inst); CanBas (Inst); Celgene (Inst); Celldex (Inst); Corcept Therapeutics (Inst); CytomX Therapeutics (Inst); Deciphera (Inst); Driver Group (Inst); Endocyte (Inst); ESSA (Inst); Five Prime Therapeutics (Inst); Fujifilm (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Halozyme (Inst); Hengrui Therapeutics (Inst); Inanovate (Inst); Incyte (Inst); Lilly (Inst); Lilly/ImClone (Inst); MabVax (Inst); Macrogenics (Inst); MedImmune (Inst); Merck Serono (Inst); Merrimack (Inst); Millennium (Inst); Minneamrita Therapeutics (Inst); Nektar (Inst); Novartis (Inst); Novita Pharmaceuticals (Inst); OncoMed (Inst); Pfizer (Inst); Phoenix Biotech (Inst); Plexxikon (Inst); Proderm IQ (Inst); Samumed (Inst); Seagen (Inst); Sirtex Medical (Inst); Strategia Therapeutics (Inst); Syndax (Inst); SynDevRx (Inst); tesaro (Inst); Tokai Pharmaceuticals (Inst); Tolero Pharmaceuticals (Inst); Toray Industries (Inst); TRACON Pharma (Inst); Trovagene (Inst); Verastem (Inst)
Patents, Royalties, Other Intellectual Property - Patient on patient selection for Clinical Trials
 
Kristen N. Ganjoo
Consulting or Advisory Role - Daiichi Sankyo; Immune Design; Janssen; Novartis
 
Margaret von Mehren
Consulting or Advisory Role - Blueprint Medicines; CytRx Corporation; deciphera; Janssen Oncology
Research Funding - ArQule
Travel, Accommodations, Expenses - Arog
Other Relationship - NCCN
 
Neeta Somaiah
Consulting or Advisory Role - Bayer; Deciphera; Immune Design
Research Funding - MedImmune
 
Jonathan C. Trent
Honoraria - GlaxoSmithKline
Consulting or Advisory Role - Janssen; Lilly; Novartis
 
Ying Su
Employment - Deciphera
Stock and Other Ownership Interests - Deciphera
 
Rodrigo Ruiz-Soto
Employment - Deciphera
Stock and Other Ownership Interests - Deciphera
 
Oliver Rosen
Employment - Deciphera
Leadership - Deciphera
Stock and Other Ownership Interests - Deciphera
 
Filip Janku
Stock and Other Ownership Interests - Trovagene
Consulting or Advisory Role - Deciphera; Foundation Medicine; Guardant Health; Immunome; Novartis; Sequenom; Trovagene
Research Funding - Agios; Astellas Pharma; BioMed Valley Discoveries; Deciphera; Fujifilm; Novartis; Piqur; Plexxikon; Roche; Symphony Evolution
Other Relationship - Bio-Rad